Senate legislation would cap insulin at $35 per month for people with private insurance
More than 2 million patients with diabetes who take insulin are privately insured, according to the Health and Human Services
Read MoreMore than 2 million patients with diabetes who take insulin are privately insured, according to the Health and Human Services
Read MoreDr. Robert Califf says in an interview with CNBC that better regulation is needed to combat health misinformation that's costing
Read MoreThe French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs
Read MoreWolfe Research identified stocks it says will outperform in the later innings of the U.S. market cycle, including during a
Read MoreNovo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following
Read MoreNames on the move ahead of the open. Source link
Read MoreSolanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms. Source
Read MoreCNBC Pro screened for names that have at least 15% upside to the average analyst price target, and a buy
Read MoreSenate Republicans killed a proposal last year to cap out-of-pocket costs at $35 for people with private insurance. Source link
Read More